During Thursday’s current trade, ITT Educational Services, Inc. (NYSE:ESI)’s shares incline 1.89% to $4.86.
ITT Educational Services, Inc. ( ESI), a leading provider of technology-oriented postsecondary degree programs, declared that it has filed its Quarterly Report on Form 10-Q for the quarter ended March 31, 2015 with the U.S. Securities and Exchange Commission. The company has now filed all periodic SEC reports required to be filed by it at this time.
The company also stated that, based on the current status of its efforts to complete the 2014 compliance audits of its institutions’ administration of the Title IV programs in which they take part, the company believes that the 2014 compliance audits should be accomplished prior to the U.S. Department of Education’s June 30, 2015 deadline.
ITT Educational Services, Inc. provides postsecondary degree programs in the United States. It offers master, bachelor, and associate degree programs to about 53,000 students; and short-term information technology and business learning solutions for career advancers and other professionals.
Intrexon Corp (NYSE:XON)‘s shares gain 1.54% to $48.93, during the current trading session Thursday’s, hitting its highest level.
Intrexon Corporation (XON) declared that it has reached a partnership with an investment fund sponsored by Harvest Capital Strategies, LLC. The fund is believed to be the world’s first that is dedicated to the inventions and discoveries of a single company.
Intrexon has agreed to provide the fund a noteworthy number of investment proposals from across five sectors – Health, Energy, Food, Environment and Consumer – that are suitable for pursuit by a startup, counting several in 2015. With respect to such proposals, Intrexon will provide the fund with exclusive rights of first-look and first negotiation. Intrexon presently sees the potential to form up to ten new companies per year, each of which will have access to Intrexon’s proprietary technology platform through an Exclusive Channel Collaboration. Although the partnership with the fund will be complimentary to programs already underway at Intrexon, nothing in the arrangement will limit the Company’s ability to execute other collaborations and joint ventures.
Intrexon Corporation, a biotechnology company, operates in the synthetic biology field in the United States. The company, through a suite of proprietary and complementary technologies, designs, builds, and regulates gene programs, which are DNA sequences that comprise of key genetic components. Its technologies comprise UltraVector gene design and fabrication platform, and its associated library of modular DNA components; cell systems informatics; RheoSwitch inducible gene switch; AttSite Recombinases; protein engineering; mAbLogix; and laser-enabled analysis and processing. Intrexon Corporation has partnership agreements with ZIOPHARM Oncology, Inc.; Synthetic Biologics, Inc.; Oragenics, Inc.; Fibrocell Science, Inc.; Genopaver, LLC; AquaBounty Technologies, Inc.; S & I Ophthalmic, LLC; Biological & Popular Culture, Inc.; OvaXon, LLC; Intrexon Energy Partners, LLC; and Persea Bio, LLC; and planned partnershipand licensing agreement with Merck Serono S.A. The company was formerly known as Genomatix Ltd. and changed its name to Intrexon Corporation in 2005. Intrexon Corporation was founded in 1998 and is based in Germantown, Maryland.
In a afternoon trade, Ascent Solar Technologies, Inc. (NASDAQ:ASTI)‘s shares surge 5.28% to $0.600.
Ascent Solar Technologies, Inc. (ASTI) declared that it reached a Stock Purchase Agreement (SPA) on June 10, 2015 with its largest stockholder, TFG Radiant Investment Group (“TFG Radiant”), for $1.0 million of common stock. The transaction is predictable to close on or before July 17, 2015.
Ascent Solar Technologies, Inc., a development stage company, designs and manufactures photovoltaic integrated consumer electronics; and portable power applications for commercial and military users. The company offers Surfr, a battery and a solar case for the Apple iPhone 4/4S smart phone, in addition to for the Samsung Galaxy S III smart phone; EnerPlex Kickr, a portable solar charging device; and EnerPlex Jumpr, a portable power bank. It also provides lithium-ion based large format batteries; Commandr XII, a solar charger; and Kickr II+ and IV+ solar products.
Solazyme Inc (NASDAQ:SZYM), during its Thursday’s current trading session -6.44% loss and closed at $3.34.
Solazyme Inc (SZYM) declared that after successfully concluding testing and product validation phases over the past year using Solazyme’s oils, Natura is purchasing Solazyme’s high-performance AlgaPūrTM Microalgae Oil, which will be incorporated into Natura’s multiple product lines.
Solazyme’s microalgae oils are produced in a matter of days using a fermentation process designed to produce oils of the highest purity, performance and sustainability. Some of the benefits of using AlgaPūr oils for skin care are higher hydration levels, a silky but not greasy skin feel, mildness on the skin, neutral color and odor, and improved shelf life.
Solazyme produces sustainable high performance ingredients for multiple markets and its joint venture facility is located in São Paulo State, in partnership with Bunge.
Solazyme, Inc. manufactures and sells renewable oils and other bioproducts. Its proprietary technology transforms a range of plant-based sugars into triglyceride oils and other bioproducts.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
